Bodilsen, Jacob;
Brouwer, Matthijs C;
D'Alessandris, Quintino Giorgio;
Humphreys, Hilary;
Iro, Mildred A;
Klein, Matthias;
Last, Katharina;
Montesinos, Inmaculada Lopez;
Pagliano, Pasquale;
San-Juan, Rafael;
Sipahi, Oguz Resat;
Tattevin, Pierre;
Thurnher, Majda;
Trevino-Rangel, Rogelio de J.
These European Society of Clinical Microbiology and Infectious Diseases guidelines are intended
for clinicians involved in diagnosis and treatment of brain abscess in children and adults.
Methods: Key questions were developed, and a systematic review was carried out of all studies published
since 1 Janua...
Ra, Jin H;
Rattan, Rishi;
Patel, Nimitt J;
Bhattacharya, Bishwajit;
Butts, Christopher A;
Gupta, Shailvi;
Asfaw, Sofya H;
Como, John J;
Sahr, Sheryl M;
Bugaev, Nikolay.
Recent studies have evaluated outcomes associated with duration of antimicrobial treatment for complicated intra-abdominal infections (cIAI). The goal of this guideline was to help clinicians better define appropriate antimicrobial duration in patients who have undergone definitive source control for cIA...
Athanazio, Rodrigo Abensur;
Tanni, Suzana Erico;
Ferreira, Juliana;
Fuccio, Marcelo de;
Marostica, Paulo José Cauduro;
Ferreira, Juliana;
Dalcin, Paulo de Tarso Roth;
Esposito, Concetta;
Canan, Mariane Gonçalves Martynychen;
Coelho, Liana Sousa;
Firmida, Mônica de Cássia;
Almeida, Marina Buarque de;
Monte, Luciana de Freitas Velloso;
Souza, Edna Lúcia;
Pinto, Leonardo Araujo;
Rached, Samia Zahi;
Oliveira, Verônica Stasiak Bednarczuk de;
Riedi, Carlos Antonio;
Silva Filho, Luiz Vicente Ribeiro Ferreira da.
A fibrose cística (FC) é uma doença genética que resulta em disfunção da proteína
reguladora de condutância transmembrana da FC (CFTR), que é um canal de cloro e
bicarbonato expresso na porção apical de células epiteliais de diversos órgãos. A
disfunção dessa proteína resulta em manifest...
Early value assessment (EVA) guidance on point-of-care tests for urinary tract infections to improve antimicrobial prescribing.
Guidance development process
Early value assessment (EVA) guidance rapidly provides recommendations on promising health technologies that have the potential to address national...
Tento Klinický doporučený postup se zabývá následujícími otázkami:
Je klinicky a ekonomicky efektivní pátrat po etiologii akutní pankreatitidy, abychom předešli opakujícím se záchvatům u lidí, u nichž etiologie není potvrzena pomocí základních vyšetření?
Jaké jsou cíle intra...
This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without ant...
Otite moyenne/traitement médicamenteux,
Anti-infectieux/usage thérapeutique,
Ordonnances médicamenteuses/normes,
Résistance microbienne aux médicaments,
Céphalosporines/usage thérapeutique,
Acétaminophène/usage thérapeutique,
Ibuprofène/usage thérapeutique,
Analgésiques non narcotiques/usage thérapeutique,
Antibactériens/usage thérapeutique,
Trouble lié au tabagisme/complications,
Placebo/usage thérapeutique,
Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques,
Surinfection/prévention et contrôle,
Amoxicilline/usage thérapeutique
Ewig, S;
Kolditz, M;
Pletz, M;
Atiner, A;
Albrich, W;
Drömann, D;
Flick, H;
Gatermann, S;
Krüger, S;
Nehls, W;
Witzenrath, M.
Die vorliegende Leitlinie umfasst ein aktualisiertes Konzept der Behandlung und Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die bisherige Leitlinie aus dem Jahre 2016 ab. Sie wurde entsprechend den Maßgaben zur Methodologie einer S3-Leitlinie erarbeitet und verabsch...
Pediatric acute myeloid leukemia (AML) requires multiple courses of intensive chemotherapy. Each course of chemotherapy destroys a child's white blood cells, called neutrophils, leaving the child in a state of neutropenia for 2 or more weeks. During neutropenia, the child is at significant risk for life-...
This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an
upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to
limit antibiotic use and reduce antibiotic resistance....
This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute
exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce
antibiotic resistance....
